- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07440498
Study of Bedroom Environment Sleep Intervention at Home for Older Adults Living Alone With Memory Concerns
February 27, 2026 updated by: Johns Hopkins University
A Pilot Feasibility Study of Bedroom Environment Sleep Intervention at Home for Older Adults Living Alone With Memory Concerns
This is an eight-week pilot research study designed to test whether simple changes to the bedroom environment along with brief sleep hygiene strategies, can improve sleep in older adults who live alone, have memory concerns, and experience insomnia symptoms.
Older adults may be eligible to participate.
The intervention will take 8 weeks, which includes 1-2 in-person visits from the research team at the participant's residence (evaluate the bedroom environment, install participant-agreed bedroom changes, deliver target sleep hygiene strategy) and 2 virtual or telephone calls (support environmental and sleep hygiene strategies) over 8 weeks.
Sleep and environment data will be collected at screening/baseline, mid-intervention (4-week) and post-intervention (8-week)
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: JUNXIN LI
- Phone Number: 4105022608
- Email: jli248@jhu.edu
Study Contact Backup
- Name: Youngmin Cho
- Email: ycho68@jh.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 65 years and older
- Living alone in a private residence or independent living setting ≥5 days/week
- Subjective cognitive decline (Subjective Cognitive Decline Questionnaire MyCog > 7] OR objective mild cognitive impairment (Montreal Cognitive Assessment [MoCA] scores between 18-25).
- Preserved Function (Functional Activity Questionnaire < 6)
- Community-dwelling
- Self-reported insomnia symptoms
- Residence in the current home for ≥3 months
- Expectation to sleep in the designated bedroom on ≥80% of nights during the 8 week protocol
Exclusion Criteria:
- Diagnosis of dementia
- Presence of acute illness or exacerbation of chronic conditions within the past month.
- Current enrollment in another intervention study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bedroom Environment Tailoring
|
Within two weeks of completing the parent study and consent, participants begin the personalized bedroom sleep environment program.
During in one or two in-home visits, a research team member will review baseline sensor and actigraphy data and install low-cost environmental modifications (e.g., blackout shades, white-noise device, air purifier, thermostat adjustments).
Participants collaborate with the coach to set stimulus-control goals and receive individualized sleep-hygiene guidance.
A 30-45-minute virtual follow-up in Weeks 2-3 reviews progress and addresses barriers, with a brief Week 6 check-in to reinforce goals.
Ongoing support includes daily self-practice, optional between-visit contact, automated reminders, and passive sensor monitoring to promote adherence and confidence in managing sleep.
|
|
Active Comparator: Sleep Health Education
The control group receives a single in-person or virtual session that provides participants with printed and online sleep health education materials.
This introductory session aims to equip participants with foundational knowledge about sleep hygiene.
Following this initial session, participants will engage in eight weeks of self-directed practice, allowing the participants to apply the information learned at the participant's own pace.
|
The control group receives a single in-person or virtual session that provides participants with printed and online sleep health education materials.
This introductory session aims to equip participants with foundational knowledge about sleep hygiene.
Following this initial session, participants will engage in eight weeks of self-directed practice, allowing the participant to apply the information learned at the participant's own pace.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Baseline, 4-weeks, 8-weeks
|
Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report measure of overall sleep quality and disturbances over the past 30 days.
It includes seven component scores-subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction-each scored 0-3 (0 = no difficulty; 3 = severe difficulty).
Component scores are summed to a global score (0-21), with higher scores indicating worse sleep quality; the global score will be used in the analysis
|
Baseline, 4-weeks, 8-weeks
|
|
Feasibility of study and intervention
Time Frame: Duration of study, approximately 2 years
|
Feasibility will be assessed by recruitment, retention, fidelity, and safety over the study period, with progression thresholds: ≥70% eligible enrollee ≥85% retained to Week 8, treatment fidelity (coaching delivered ≥80%), and no serious intervention-related adverse events.
|
Duration of study, approximately 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Junxin Li, PhD, RN, Johns Hopkins University School of Nursing
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2028
Study Registration Dates
First Submitted
February 23, 2026
First Submitted That Met QC Criteria
February 23, 2026
First Posted (Actual)
February 27, 2026
Study Record Updates
Last Update Posted (Actual)
March 2, 2026
Last Update Submitted That Met QC Criteria
February 27, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00543636
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteRecruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Completed
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
Clinical Trials on Bedroom Environment Tailoring
-
Virginia Commonwealth UniversityAmerican Cancer Society, Inc.CompletedLymphoma | Leukemia | MyelomaUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedEmergencies | Covid19France
-
Chun ChaoPatient-Centered Outcomes Research InstituteRecruitingCervical Cancer | Health Knowledge, Attitudes, Practice | Health Care Utilization | Human PapillomavirusUnited States
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedUrinary Incontinence in Old Age | Fecal Incontinence in Old AgeUnited States
-
Instituto de Investigación Hospital Universitario...CompletedBreast Cancer | Vascularization | Fat NecrosisSpain
-
University of MichiganNational Cancer Institute (NCI)CompletedPrevention | Human PapillomavirusUnited States
-
University of MichiganCompletedMeasles | Rubella | Mumps | MMR VaccinationUnited States
-
Truth InitiativeCompletedSmoking CessationUnited States
-
Kaiser PermanenteNational Cancer Institute (NCI)Recruiting
-
UMC UtrechtRudolf Magnus Institute - University of UtrechtUnknownRefractory Localization-related EpilepsyNetherlands